CAS RN: 113617-63-3
Orbifloxacin
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20250708
100mg / 250mg / 1g / 5g
Confirm by inquiry
Shanghai, Shandong 5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 113617-63-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
113617-63-3 / 1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid
ORBIFLOXACIN | Orbax | orbifloxacine
Standard CAS: 113617-63-3
Multi CAS: Yes
Basic Information
copy
CAS
113617-63-3 copy
Multi CAS
Yes copy
Molecular Formula
C19H20F3N3O3 copy
Molecular Weight
395.400000 copy
Exact Mass
395.145676 copy
SMILES
C[C@@H]1CN(C[C@@H](N1)C)C2=C(C3=C(C(=C2F)F)C(=O)C(=CN3C4CC4)C(=O)O)F copy
InChI
InChI=1S/C19H20F3N3O3/c1-8-5-24(6-9(2)23-8)17-14(21)13(20)12-16(15(17)22)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6H2,1-2H3,(H,27,28)/t8-,9+ copy
InChIKey
QIPQASLPWJVQMH-DTORHVGOSA-N copy
Synonyms
ORBIFLOXACIN
Orbax
orbifloxacine
orbifloxacino
NSC-758614 copy
Computed Properties
copy
Structural Parameters
Heavy atom count
28 copy
Aromatic heavy atom count
10 copy
Fraction Csp3
0.47 copy
Rotatable bonds
3 copy
H-bond acceptors
5 copy
H-bond donors
2 copy
Molar refractivity
97.59 copy
TPSA
74.57 copy
LogP / Solubility
WLOGP
2.64 copy
MLOGP
2.35 copy
XLogP3
0.9 copy
Consensus LogP
1.96 copy
Log S (ESOL)
-4.02 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-4.71 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.78 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-3.26 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
4 copy
Safety & Transport
copy
Pictogram(s)
Health Hazard copy
Signal
Warning copy
GHS Hazard Statements
H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] copy
Precautionary Statement Codes
P203, P280, P318, P405, and P501 copy